Development of immediate and sustained-release formulations of the glucagon-like peptide-1 receptor agonist exenatide for the treatment of patients with type 2 diabetes

M.S. Fineman

Research output: ThesisResearch external, graduation VU University Amsterdam

51 Downloads (Pure)
Original languageEnglish
QualificationDoctor of Philosophy
Awarding Institution
  • VU Vrije Universiteit
Supervisors/Advisors
  • Diamant, M., Supervisor
  • Heine, R.J., Supervisor
Award date9 Sep 2011
Publication statusPublished - 2011

Cite this